CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less radiation after surgery keep throat cancer in check with fewer side effects?
Disease control OngoingThis study is for people with HPV-positive throat cancer, a type that usually responds well to treatment. After robotic surgery to remove the tumor, participants receive a lower dose of radiation than the standard amount. The goal is to see if this gentler approach can still cont…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
Could less radiation be enough? new study tests kinder treatment for HPV throat cancer
Disease control OngoingThis study looks at whether a lower dose of radiation combined with the immunotherapy drug nivolumab can control early-stage HPV-positive throat cancer as well as the standard higher-dose radiation plus chemotherapy (cisplatin). The trial includes 384 non-smoking patients with ea…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:04 UTC